Osteoprotegerin levels are increased in serum of patients with multiple myeloma.

被引：0
|
作者：
Corso, A
Dovio, A
Sartori, ML
Rusconi, C
Klersy, C
Mangiacavalli, S
Zappasodi, P
Varettoni, M
Angeli, A
Lazzarino, M
机构：
[1] IRCCS Policlin San Matteo, Div Hematol, Pavia, Italy
[2] Univ Turin, Dipartimento Sci Clin & Biol, I-10124 Turin, Italy
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5196
引用
收藏
页码：367B / 367B
页数：1
相关论文
共 50 条
  • [1] Influence of renal failure on the osteoprotegerin level in patients with multiple myeloma.
    Goranov, Stefcho
    Goranova-Marinova, Veselina
    Kumchev, Emil
    Pavlov, Pavel
    Tzvetkova, Todorka
    BLOOD, 2006, 108 (11) : 338B - 338B
  • [2] Osteoprotegerin/sRANKL ratio is increased in bone marrow and serum of multiple myeloma patients
    Kraj, M
    Sokolowska, U
    Centkowski, P
    Kruk, B
    IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION, 2004, : 465 - 468
  • [3] Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease
    Seidel, C
    Hjertner, O
    Abildgaard, N
    Heickendorff, L
    Hjorth, M
    Westin, J
    Nielsen, JL
    Hjorth-Hansen, H
    Waage, A
    Sundan, A
    Borset, M
    BLOOD, 2001, 98 (07) : 2269 - 2271
  • [4] Zoledronic acid early increases serum osteoprotegerin in early stage multiple myeloma.
    Gozzetti, Alessandro
    Martini, Giuseppe
    Salvadori, Stefania
    Gennari, Luigi
    Avanzati, Annalisa
    Franci, Beatrice
    Carnpagna, Maria Stella
    Nuti, Ranuccio
    Lauria, Francesco
    BLOOD, 2006, 108 (11) : 1025A - 1025A
  • [5] Plasma cobalamin levels of patients with multiple myeloma.
    Hine, RJ
    Zangari, M
    FASEB JOURNAL, 2002, 16 (05) : A747 - A747
  • [6] Serum syndecan (CD138) levels are increased in patients with symptomatic multiple myeloma compared to normal controls, MGUS, and smoldering myeloma.
    Kumar, S
    Ahmann, G
    Witzig, TE
    Kyle, RA
    Greipp, PR
    BLOOD, 2002, 100 (11) : 806A - 807A
  • [7] Serum transforming growth factor beta 1 levels in multiple myeloma.
    Coskun, HS
    Ilhan, O
    Özcan, M
    Ayaz, S
    Dalva, K
    Üstün, C
    Arat, M
    Beksaç, M
    BLOOD, 1998, 92 (10) : 262B - 262B
  • [8] Association of venous thromboembolism with increased mortality in patients with multiple myeloma.
    Schoen, Martin W.
    Luo, Suhong
    Gage, Brian
    Carson, Kenneth Robert
    Sanfilippo, Kristen Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Serum osteoprotegerin levels are increased in patients with advanced prostate cancer
    Brown, JM
    Vessella, RL
    Kostenuik, PJ
    Dunstan, CR
    Lange, PH
    Corey, E
    CLINICAL CANCER RESEARCH, 2001, 7 (10) : 2977 - 2983
  • [10] Serum free light chain levels in patients with intact immunoglobulin myeloma.
    Carr-Smith, HD
    Mead, GP
    Smith, L
    Drayson, MT
    Bradwell, AR
    CLINICAL CHEMISTRY, 2003, 49 (06) : A107 - A107
12345